Cargando…

A novel BCMA CAR-T-cell therapy with optimized human scFv for treatment of relapsed/refractory multiple myeloma: results from phase I clinical trials

Detalles Bibliográficos
Autores principales: Yang, Min, Zhang, Wenhao, Yu, Kang, Wang, Peng, Jiang, Hua, Chen, Linjun, Meng, Haitao, Weng, Yiqin, Tao, Rong, Huang, Xin, Xing, Chongyun, Wang, Huamao, Wan, Jiangbo, Wang, Shasha, Dai, Lihui, Hendrix, Amanda Y., Xiao, Jun, Wang, Wei, Ma, Hong, Hao, Siguo, Jin, Jie, Li, Zonghai, Jiang, Songfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335117/
https://www.ncbi.nlm.nih.gov/pubmed/35443566
http://dx.doi.org/10.3324/haematol.2022.280629

Ejemplares similares